Juergen Eckhardt
CIK: 0001857806
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
MGX
Metagenomi Therapeutics, Inc.
Director
Discretionary Trading P&L
Holdings
About Eckhardt Juergen
Eckhardt Juergen (SEC CIK 0001857806) files insider reports with the SEC as Director of Metagenomi Therapeutics, Inc. (MGX).
Signal8 holds 2 ownership filings by Eckhardt Juergen, all Form 4s, filed between Jun 12, 2025 and Jun 11, 2026. Those filings report 2 transactions, from Jun 10, 2025 to Jun 9, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Eckhardt Juergen's filings is in EMERYVILLE, CA.
Recent filings by Eckhardt Juergen
Other insiders filing for Metagenomi Therapeutics, Inc. (MGX)
- Reid Laurence, Director
- Wein Matthew
- Irish Jian
- Wapnick Pamela, Chief Financial Officer
- Dere Willard H, Director
- BJERKHOLT ERIC, Director